The index single-nucleotide polymorphism (SNP) of the main association was rs10305420 ( P = 2.9 10 10 , reference allele C, effect allele T), which conferred an additional 0.641% BMI loss per T allele, approximately equivalent to an additional 0.76 kg weight loss per allele (95% CI, [1.27, 0.34] kg)
"Wegovy is a once-weekly injection that was developed for long-term weight management, while phentermine is a daily oral medication only meant for short-term use of up to three months, although it may be continued for longer," Vukasinov says
And we do not know whether the migraine benefit is specific to people with obesity or extends to normal-weight migraineurs
(Many people use Ozempic off label for weight loss, though it is not FDA-approved for such.) These medications seem to promote weight loss through two mechanisms that, again, mimic the action of endogenous GLP-1: They delay gastric emptying: The sensation of fullness caused by slower gastric emptying can prompt people to eat less, thus helping them lose weight over time
The important point is that early data suggest lean mass loss was similar between calorie restriction alone and calorie restriction plus the peptide